Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GEN ILAC) aktie
GENIL.IS
Fördröjd 15 minGEN ILAC
Market Cap
$38,122,409,984
Om Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GEN ILAC) aktie
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Företagsinformation
06520 Çankaya, Turkey
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.